NRAS and acute myeloid leukemia: However, given the prevalence of NRAS mutations in AML, there is urgently need to explore the clinical characteristics, companion gene mutations and possible prognostic factors of NRASmut AML patients to provide evidence for clinical stratified diagnosis and treatment.